Intellectual Property India Publishes Patent Application for Lipid Nanoparticles Comprising Coding Rna Molecules For Use In Gene Editing And As Vaccines And Therapeutic Agents

MUMBAI, India, Aug. 31 -- Intellectual Property India has published a patent application (202617081738 A) filed by Renagade Therapeutics; and Orna Therapeutics, Inc. on July 02, 2026, for Lipid Nanoparticles Comprising Coding Rna Molecules For Use In Gene Editing And As Vaccines And Therapeutic Agents.

Inventors include Jayaraman, Muthusamy; Sankaran, Ganapathy Subramanian No; Smith, David Townsend; Rhym, Luke Hyunsik; Narayanan, Elisabeth; John, Shinu Application Number; Wang, Yinghua; Kosakowska, Karolina Anna; Bolen, Joseph Number; Presnyak, Vladimir; and Pepin, Christopher Stephen.

The application for the patent was published on August 28, 2026, under issue no. 35/2026.

Abstract: The present disclosure describes improved LNP-based RN...